| H1N1 influenza is here. | |
| | |
MedLine Citation:
|
PMID: 19765859 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
On 11 June WHO announced that the spread of H1N1 had reached pandemic phase 6. Since then countries around the world have increased their planning and preparedness for the continuing pandemic. Guidelines have been issued and circulated but confusion continues over their interpretation. We need to remind ourselves of the principles behind control measures and educate and reinforce standard infection control procedures in the acute hospital setting. |
| | |
Authors:
|
S M Burns |
Related Documents
:
|
7985819 - Demand for isolation beds in a pediatric hospital. 17870669 - Hospital-acquired legionellosis originating from a cooling tower during a period of the... 20404459 - Correlations between genotyping and antibiograms of clinical isolates of pseudomonas ae... 17049419 - Prevalence of hospital-acquired urinary tract infections in urology departments. 20191189 - Vancomycin use in a brazilian teaching hospital: comparison with the hospital infection... 9202819 - Status of tuberculosis infection control programs at texas hospitals, 1989 through 1991. 19782979 - Inequalities in cesarean delivery rates by ethnicity and hospital accessibility in brazil. 9189299 - Internet resources for family physicians. 12061109 - The ecological footprint of lions gate hospital. |
Publication Detail:
|
Type: Journal Article Date: 2009-09-17 |
Journal Detail:
|
Title: The Journal of hospital infection Volume: 73 ISSN: 1532-2939 ISO Abbreviation: J. Hosp. Infect. Publication Date: 2009 Nov |
Date Detail:
|
Created Date: 2009-10-19 Completed Date: 2010-01-12 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8007166 Medline TA: J Hosp Infect Country: England |
Other Details:
|
Languages: eng Pagination: 200-2 Citation Subset: IM |
Affiliation:
|
Royal Infirmary of Edinburgh, Edinburgh, UK. SM.Burns@luht.scot.nhs.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antiviral Agents
/
administration & dosage Cross Infection* / drug therapy, epidemiology, prevention & control, virology Disaster Planning / methods Disease Outbreaks* Health Personnel Humans Infection Control / methods* Infectious Disease Transmission, Patient-to-Professional / prevention & control Infectious Disease Transmission, Professional-to-Patient / prevention & control Influenza A Virus, H1N1 Subtype* Influenza, Human* / drug therapy, epidemiology, prevention & control, virology Neuraminidase / antagonists & inhibitors Patient Isolation Practice Guidelines as Topic |
| Chemical | |
Reg. No./Substance:
|
0/Antiviral Agents; EC 3.2.1.18/Neuraminidase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Phosphorylation of mitogen-activated protein kinase (MAPK) is required for cytokinesis and progressi...
Next Document: Responsibility for managing healthcare-associated infections: where does the buck stop?